GGrantIndex
Sort

130,381 grants matching hiv

HIV & AIDS PREVENTION AND PALLIATIVE CARE FOR TEACHERS, ORPHANS AND VUNERABLE

$1,512,427
Nomfundo Mkhulisi · South African Democratic Teacher'S Union · U2G · FY2009 · PS

Molecular Epidemiology of non Hodgkin's Lymphoma

$1,512,319
University Of California San Francisco · R01 · FY2004 · CA

Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center

$1,512,315
Shilpa J Buch · University Of Nebraska Medical Center · P30 · FY2020 · MH

ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS

$1,512,195
University Of Maryland Baltimore · U01 · FY2001 · HD

HIV Center for Clinical and Behavioral Studies

$1,512,117
Robert H Remien · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P30 · FY2020 · MH

HIV Center for Clinical and Behavioral Studies

$1,512,117
Robert H Remien · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P30 · FY2022 · MH

UCLA CENTER FOR AIDS RESEARCH (CFAR)

$1,512,031
University Of California Los Angeles · P30 · FY2001 · AI

Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV

$1,512,004
Marya Gwadz · New York University · R01 · FY2014 · DA

Adjuvant discovery for vaccines against West Nile Virus and Influenza

$1,511,799
Herman Staats · Duke University · N01 · FY2017 · AI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy

$1,511,798
Richard T D'aquila · Northwestern University At Chicago · P01 · FY2021 · AI

Cape Town Clinical Trials Unit (CT-CTU) for HIV/AIDS Prevention & Treatment

$1,511,717
Robin Wood · University Of Cape Town · U01 · FY2008 · AI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM

$1,511,671
University Of Hawaii At Manoa · U01 · FY2003 · AI

Immunotherapeutic Approaches for AIDS

$1,511,661
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Core B - Developmental

$1,511,633
Ira B Wilson · Miriam Hospital · P30 · FY2020 · AI

HIV-1 SHEDDING FROM FEMALE GENITAL TRACT

$1,511,632
University Of Washington · P01 · FY2003 · HD

Optimizing HIV-care-continuum engagement and outcomes among opioid users

$1,511,604
David Epstein · National Institute On Drug Abuse · ZIA · FY2018 · DA

Optimizing HIV-care-continuum engagement and outcomes among opioid users

$1,511,604
David Epstein · National Institute On Drug Abuse · ZIA · FY2019 · DA

GENERAL CLINICAL RESEARCH CENTER

$1,511,495
University Of Connecticut Sch Of Med/Dnt · M01 · FY2000 · RR

San Francisco Bay Clinical Trials Unit (CTU)

$1,511,389
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2022 · AI

HIV Disease Outcomes in Drug Users in Clinical Practice

$1,511,362
Richard Douglas Moore · Johns Hopkins University · U01 · FY2014 · DA

ADULT AIDS CLINICAL TRIALS UNIT

$1,511,271
University Of California San Francisco · U01 · FY2004 · AI

Unraveling the Mechanisms of HIV Persistence and Rebound

$1,510,986
Thomas Hope · Northwestern University At Chicago · P01 · FY2022 · AI

Immunological Strategies to Modulate SIV Rebound Following ART Interruption

$1,510,883
Michael R Betts · University Of Pennsylvania · P01 · FY2020 · AI

ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU

$1,510,774
University Of Puerto Rico Med Sciences · U01 · FY2001 · AI

Cell Interactions in Three Dimensional Tissue Culture

$1,510,692
Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD